We are excited to announce the ten companies joining us in Los Angeles for our Q4 2017 class of the Cedars-Sinai Accelerator, Powered by Techstars. Our program kicked off last week on September 12, and we are excited to help accelerate another generation of transformative healthcare technology companies. Our Demo Day will be held on December 6.
This is the third program of the Cedars-Sinai Accelerator, and we’re excited to continue the momentum built by our last two classes ofextraordinary companies and founders. We’re thankful to have their support as well as the dedication and expertise of ourmentors, whose #GiveFirst attitude and commitment to supporting our healthcare tech entrepreneurs not only drives the success of this program, but the future of patient care.
We are proud to be part of the thriving technology community here in Los Angeles, which now includes three Techstars programs (ours,Techstars Music, andTechstars LA)!
Please welcome the Cedars-Sinai Accelerator, Powered by Techstars companies:
provides a voice assistant platform built for patient care and staff efficiency. Patients enjoy hands-free access to information, reminders and entertainment, while Aiva triages voice requests to the right caregiver’s mobile device leveraging artificial intelligence to reduce response times and greatly improve the patient experience.
is an app for oncology patients, caregivers and clinicians to improve the way cancer care is coordinated. The app offers patients personalized cancer information, organizes their journey, provides unique telemedicine and connects them to a community for support.
is a tool for clinicians and patients to engage in shared decision making about treatment options. Its software personalizes recommendations based on each patient’s clinical condition and personal preferences and provides providers a tool to best communicate and engage patients.
uses machine learning and AI to offer patients a triage tool that leads from symptoms to information to recommended next steps. Using a conversational agent, either through messaging or voice-enabled technology, GYANT uses clinically validated triage-protocols to ensure patients have immediate access to information and can appropriately access the right level of care.
is a cloud based, content management platform for managing clinical trial documents and workflows that replaces paper subject and regulatory binders. Regulatory documents can be distributed, controlled, and collected within SourceDrive, helping to ensure accuracy and completeness.
utilizes context-aware automation to engage patients and physicians to drive adherence to protocols. Lumeon’s Care Pathway Management (CPM) platform allows hospitals to create their own end-to- end workflows that use digital protocols to control all processes throughout the patient journey, from appointment generation through to follow-up.
is an artificial intelligence platform specifically for analyzing patient experience. Utilizing a cloud-based, HIPAA-compliant, healthcare-specific Natural Language Processing and Machine Learning platform, NarrativeDx collects, analyzes, and visualizes unstructured patient feedback from internal and external sources (CAHPS Surveys, grievance letters, social review sites, etc.).
service is a mobile care coordination solution. It enables remote care management for high-risk patients and connects patients and their caregivers to the care team during the most critical points of care.
helps providers rapidly deliver evidence-based preventative counseling at the point of care. Their software captures relevant patient medical history prior to a visit, enables providers to deliver brief, personalized preventative interventions during normal office visits, and ensures reliable reimbursement by automating notes and billing for preventive services.
is an easy-to-use, virtually painless, and wearable blood collection system that uses microfluidic technology which will allow patients to collect their own blood samples. The blood collected by the HemoLink can be used by third-party labs across a broad range of diagnostic tests.
Matt Kozlov Matt is the Managing Director of the Cedars-Sinai Accelerator, Powered by Techstars. Previously Matt was Head of Corporate Development at Telesign and the CEO of Moonshark, a venture backed by Creative Artists Agency (CAA). He has also worked at Sony Music Entertainment, Yahoo! and Bain and Company. Matt is an advisor to several LA-based companies including Chromatik, Vyng, Rattleback Rye and Alpha Edison. He graduated from Harvard, where he studied economics. @Koz